RNA therapeutics

REDWOOD CITY, Calif. — September 28, 2026 Codexis, Inc. announced an agreement with a pioneering siRNA drug innovator to...

CAMBRIDGE, UK — September 28, 2026 4basebio PLC announced a collaboration with TriLink BioTechnologies, part of Maravai LifeSciences, to...

CAMBRIDGE, Mass. — September 23, 2026 Wave Life Sciences announced the initiation of a Phase 2a clinical trial evaluating...

SAN DIEGO — September 18, 2026 Arcturus Therapeutics announced plans to provide an update on its ARCT-810 Phase 2...

Cambridge, Massachusetts, September 15, 2026 QurCan Therapeutics has entered into a strategic research and collaboration agreement with Eli Lilly...

Waltham, Massachusetts, USA, September 8, 2026 NanoMosaic has joined a Mass General Brigham-led consortium selected for the Advanced Research...

Crystal Lake, Illinois — September 7, 2026 Aptar Pharma announced a collaboration with Aceso Therapeutics to advance development activities...

Seoul, South Korea, September 7, 2026 RZNOMICS Inc., a biopharmaceutical company focused on RNA-based gene therapies, has reported major...

Carlsbad, California — September 4, 2026 Ionis Pharmaceuticals and partner Novartis reported topline results from the Phase 3 Lp(a)HORIZON...

CARLSBAD, California, August 20, 2026 Ionis Pharmaceuticals, Inc. announced that new clinical data supporting its severe hypertriglyceridemia (sHTG) treatment...